4'-iodo-4'-deoxydoxorubicin

DRUG2 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Multiple Myeloma and Plasma Cell NeoplasmPrimary Systemic Amyloidosis

Phase 1

Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis

TerminatedNCT00030381

National Cancer Institute (NCI)Primary Systemic Amyloidosis

Start: 2001-12-31Updated: 2013-01-16

Phase 2

4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis

CompletedNCT00003853

National Cancer Institute (NCI)Multiple Myeloma and Plasma Cell Neoplasm

Start: 1999-04-30End: 2001-08-31Target: 45Updated: 2012-11-12